MPT
Medical Properties·NYSE
--
--(--)
--
--(--)
MPT fundamentals
Medical Properties (MPT) released its earnings on Feb 19, 2026: revenue was 270.34M (YoY +16.61%), beat estimates; EPS was 0.03 (YoY +104.35%), beat estimates.
Revenue / YoY
270.34M
+16.61%
EPS / YoY
0.03
+104.35%
Report date
Feb 19, 2026
MPT Earnings Call Summary for Q4,2025
- Strong Portfolio Growth: EBITDARM coverage at 2.6x, with post-acute operators up 28% and Ernest Health up 15%.
- Strategic Acquisitions: $32M California and EUR 23M European post-acute facilities acquired; 6 underperforming properties sold.
- Financial Stability: $0.18 Q4 FFO driven by $18M Vibra payment; $70M Prospect proceeds collected.
- Debt Management: EUR 500M notes refinanced at 0.99%; $150M share buyback completed.
- 2026 Outlook: Target $1B annualized rent, with NOR ramping to full payment by year-end.
- Behavioral Health Challenges: U.K. market headwinds and U.S. labor costs impacting performance.
EPS
Actual | 0.15 | 0.21 | 0.25 | 0.2 | 0.28 | 0.19 | 0.29 | 0.34 | 1.05 | 0.32 | 0.37 | -0.24 | 0.05 | -0.07 | 0.19 | -1.11 | -1.23 | -0.54 | -1.34 | -0.69 | -0.2 | -0.16 | -0.13 | 0.03 | |||||||||||
Forecast | 0.284 | 0.2557 | 0.2579 | 0.2664 | 0.2627 | 0.2853 | 0.2818 | 0.3107 | 0.3055 | 0.2955 | 0.3014 | 0.2741 | 0.2225 | 0.2177 | 0.1915 | 0.1459 | 0.0899 | 0.0445 | 0.0243 | -0.058 | 0.0107 | -0.0014 | 0.0118 | 0.013 | |||||||||||
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -47.18% | -17.87% | -3.06% | -24.92% | +6.59% | -33.40% | +2.91% | +9.43% | +243.70% | +8.29% | +22.76% | -187.56% | -77.53% | -132.15% | -0.78% | -860.80% | -1468.19% | -1313.48% | -5614.40% | -1089.66% | -1969.16% | -11328.57% | -1201.69% | +130.77% |
Revenue
Actual | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 294.13M | 291.84M | 329.46M | 333.81M | 362.76M | 381.79M | 390.78M | 409.33M | 409.80M | 400.23M | 352.34M | 380.49M | 350.21M | 337.39M | 306.58M | -122.38M | 271.32M | 266.56M | 225.83M | 231.84M | 223.80M | 240.36M | 237.52M | 270.34M |
Forecast | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 298.33M | 296.23M | 308.72M | 327.09M | 338.50M | 360.58M | 379.68M | 395.11M | 399.52M | 394.25M | 383.57M | 364.71M | 347.51M | 344.44M | 333.98M | 300.77M | 270.14M | 259.53M | 254.20M | 229.68M | 229.99M | 224.81M | 234.02M | 238.95M |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -1.41% | -1.48% | +6.72% | +2.05% | +7.17% | +5.88% | +2.92% | +3.60% | +2.57% | +1.52% | -8.14% | +4.33% | +0.78% | -2.04% | -8.21% | -140.69% | +0.44% | +2.71% | -11.16% | +0.94% | -2.69% | +6.92% | +1.50% | +13.14% |
Earnings Call
You can ask Aime
What is Medical Properties's gross profit margin?What is the revenue and EPS growth rate for Medical Properties year over year?What were the key takeaways from Medical Properties's earnings call?What does Medical Properties do and what are its main business segments?What is the market's earnings forecast for Medical Properties next quarter?What factors drove the changes in Medical Properties's revenue and profit?What guidance did Medical Properties's management provide for the next earnings period?Did Medical Properties beat or miss consensus estimates last quarter?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
